96 related articles for article (PubMed ID: 24377620)
1. Conventional radiotherapy with concurrent weekly Cisplatin in locally advanced head and neck cancers of squamous cell origin - a single institution experience.
Dimri K; Pandey AK; Trehan R; Rai B; Kumar A
Asian Pac J Cancer Prev; 2013; 14(11):6883-8. PubMed ID: 24377620
[TBL] [Abstract][Full Text] [Related]
2. Radical radiotherapy with concurrent weekly cisplatin in loco-regionally advanced squamous cell carcinoma of the head and neck: a single-institution experience.
Gupta T; Agarwal JP; Ghosh-Laskar S; Parikh PM; D'Cruz AK; Dinshaw KA
Head Neck Oncol; 2009 Jun; 1():17. PubMed ID: 19527507
[TBL] [Abstract][Full Text] [Related]
3. Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and neck cancer.
Heukelom J; Hamming O; Bartelink H; Hoebers F; Giralt J; Herlestam T; Verheij M; van den Brekel M; Vogel W; Slevin N; Deutsch E; Sonke JJ; Lambin P; Rasch C
BMC Cancer; 2013 Feb; 13():84. PubMed ID: 23433435
[TBL] [Abstract][Full Text] [Related]
4. Concurrent radiochemotherapy in locally-regionally advanced oropharyngeal squamous cell carcinoma: analysis of treatment results and prognostic factors.
Krstevska V; Stojkovski I; Zafirova-Ivanovska B
Radiat Oncol; 2012 May; 7():78. PubMed ID: 22640662
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of bevacizumab in combination with docetaxel and radiation in locally advanced squamous cell carcinoma of the head and neck.
Yao M; Galanopoulos N; Lavertu P; Fu P; Gibson M; Argiris A; Rezaee R; Zender C; Wasman J; Machtay M; Savvides P
Head Neck; 2015 Nov; 37(11):1665-71. PubMed ID: 24954745
[TBL] [Abstract][Full Text] [Related]
6. Prospective Study to Compare Efficacy of Conventional Chemoradiotherapy with Hypofractionated Chemoradiotherapy in Locally Advanced Carcinoma of Oropharynx.
Dwivedi A; Raza MW; Prasad SN; Singh A
Asian Pac J Cancer Prev; 2023 Dec; 24(12):4077-4083. PubMed ID: 38156840
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin Every 3 Weeks Versus Weekly With Definitive Concurrent Radiotherapy for Squamous Cell Carcinoma of the Head and Neck.
Bauml JM; Vinnakota R; Anna Park YH; Bates SE; Fojo T; Aggarwal C; Limaye S; Damjanov N; Di Stefano J; Ciunci C; Genden EM; Wisnivesky JP; Ferrandino R; Mamtani R; Langer CJ; Cohen RB; Sigel K
J Natl Cancer Inst; 2019 May; 111(5):490-497. PubMed ID: 30239887
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of erlotinib and docetaxel with concurrent intensity-modulated radiotherapy in locally advanced head and neck squamous cell carcinoma.
Yao M; Woods C; Lavertu P; Fu P; Gibson M; Rezaee R; Zender C; Wasman J; Sharma N; Machtay M; Savvides P
Head Neck; 2016 Apr; 38 Suppl 1(Suppl 1):E1770-6. PubMed ID: 26918562
[TBL] [Abstract][Full Text] [Related]
9. Retrospective Analysis of Cisplatin Nephrotoxicity in Patients With Head and Neck Cancer Receiving Outpatient Treatment With Concurrent High-dose Cisplatin and Radiotherapy.
Faig J; Haughton M; Taylor RC; D'Agostino RB; Whelen MJ; Porosnicu Rodriguez KA; Bonomi M; Murea M; Porosnicu M
Am J Clin Oncol; 2018 May; 41(5):432-440. PubMed ID: 27281266
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of the treatment outcome of moderately accelerated radiation fractionation (with concurrent chemotherapy in daily dosing) to conventional chemo-radiotherapy in locally advanced head and neck cancers: Supportive in a resource constrained environment.
Arora C; Sharma N; Kapoor A; Pandya TN
Indian J Cancer; 2023 May; ():. PubMed ID: 38090961
[TBL] [Abstract][Full Text] [Related]
11. Chemoradiotherapy with high-dose cisplatin compared with weekly cisplatin for locally advanced head and neck squamous cell carcinoma.
Hughes RT; Porosnicu M; Levine BJ; Lycan TW; Shenker RF; Frizzell BA; Greven KM
J Med Imaging Radiat Oncol; 2021 Oct; 65(6):796-805. PubMed ID: 34309212
[TBL] [Abstract][Full Text] [Related]
12. Current status and future perspective of postoperative treatment for locally advanced squamous cell carcinoma of the head and neck.
Kiyota N; Tahara M; Homma A
Jpn J Clin Oncol; 2024 Jun; 54(6):613-619. PubMed ID: 38452121
[TBL] [Abstract][Full Text] [Related]
13. Accelerated hypofractionated chemoradiation for locally advanced head and neck cancer during COVID 19 pandemic: A tertiary care experience.
Agarwal S; Jaiswal I; Shahi UP; Mandal A; Aggarwal LM; Singh A; Jaiswal A; Yadawa N
J Cancer Res Ther; 2024 Jan; 20(1):404-409. PubMed ID: 38554353
[TBL] [Abstract][Full Text] [Related]
14. Treatment outcomes of radiotherapy with concurrent weekly cisplatin in older patients with locally advanced head and neck squamous cell carcinoma.
Uchinami Y; Yasuda K; Kano S; Otsuka M; Hamada S; Suzuki T; Tsushima N; Takahashi S; Fujita Y; Miyazaki T; Higaki H; Taguchi J; Shimizu Y; Sakashita T; Homma A; Aoyama H
Discov Oncol; 2023 Dec; 14(1):226. PubMed ID: 38063923
[TBL] [Abstract][Full Text] [Related]
15. Pre-treatment risk factors to predict early cisplatin-related nephrotoxicity in locally advanced head and neck cancer patients treated with chemoradiation: A single Institution experience.
Cavalieri S; Platini F; Barretta F; Nuzzolese I; Ottini A; Bergamini C; Resteghini C; Colombo E; Iacovelli NA; Franceschini M; Calareso G; Di Pede P; De Feo G; Gandelli M; Toffolatti L; Guglielmo M; Ripamonti CI; Cosmai L; Licitra L; Alfieri S
Oral Oncol; 2023 Nov; 146():106579. PubMed ID: 37778228
[TBL] [Abstract][Full Text] [Related]
16. Pre-radiotherapy Haemoglobin Level is A Prognosticator in Locally Advanced Head and Neck Cancers Treated with Concurrent Chemoradiation.
Narayanaswamy RK; Potharaju M; Vaidhyswaran AN; Perumal K
J Clin Diagn Res; 2015 Jun; 9(6):XC14-XC18. PubMed ID: 26266202
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Acute Side Effects Among 3D-Concurrent Radiotherapy With Cisplatin-Treated Head and Neck Cancer Patients.
Mehmood H; Laique T; Ahmad A; Ahmad R
Cureus; 2023 Aug; 15(8):e44238. PubMed ID: 37772219
[TBL] [Abstract][Full Text] [Related]
18. A Prospective Randomised Comparative Study Between Weekly Cisplatin Versus Three Weekly Cisplatin with Radiotherapy in Unresectable Locally Advanced Head and Neck Cancer.
Panihar C; Rawat S; Singotia L; Raj A; Jain RK
Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):2670-2675. PubMed ID: 36452529
[TBL] [Abstract][Full Text] [Related]
19. Dose-Finding and Efficacy Confirmation Trial of the Superselective Intra-arterial Infusion of Cisplatin and Concomitant Radiation Therapy for Locally Advanced Maxillary Sinus Cancer (JCOG1212): Results of the Efficacy Confirmation Phase in Patients with T4aN0M0.
Homma A; Mikami M; Matsuura K; Onimaru R; Yoshida D; Shinomiya H; Ohkoshi A; Hayashi R; Saito Y; Tachibana H; Shiga K; Ueda T; Uemura H; Nakamura K; Fukuda H;
Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1271-1281. PubMed ID: 38008195
[TBL] [Abstract][Full Text] [Related]
20. Weekly versus 3-weekly cisplatin along with radiotherapy for locoregionally advanced non-nasopharyngeal head and neck cancers: Is the equipoise in literature addressed yet?
Chatterjee S; Kiyota N; Vaish R; Sharma A; Tahara M; Noronha V; Prabhash K; D'Cruz A
Head Neck; 2023 Jun; 45(6):1594-1603. PubMed ID: 37019856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
